Works matching IS 17555914 AND DT 2018 AND VI 36 AND IP 1

Results: 9

Hemodynamic impact of pulmonary vasodilators on single ventricle physiology.

Published in:

Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12314

By:

Castaldi, Biagio;
Bordin, Giulia;
Padalino, Massimo;
Cuppini, Elena;
Vida, Vladimiro;
Milanesi, Ornella

Publication type:

Article

The effect of allogeneic cardiac stem cells in left ventricular geometry and function in a rat model of myocardial infarction.

Published in:

Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12313

By:

Weng, Yinlun;
Zhang, Xueyuan;
Liu, Anmin;
Cai, Wangqing;
Li, Fangcheng;
Wang, Tong

Publication type:

Article

Tetrahydrobiopterin (BH4): Targeting endothelial nitric oxide synthase as a potential therapy for pulmonary hypertension.

Published in:

Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12312

By:

Francis, Bahaa N.;
Salameh, Maram;
Khamisy‐Farah, Rola;
Farah, Raymond

Publication type:

Article

Issue Information.

Published in:: Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12293
Publication type:: Article

The APEX trial: Effects of allopurinol on exercise capacity, coronary and peripheral endothelial function, and natriuretic peptides in patients with cardiac syndrome X.

Published in:

Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12311

By:

Lim, Tiong Keng;
Noman, Awson;
Choy, Anna Maria J.;
Khan, Faisel;
Struthers, Allan D.;
Lang, Chim C.

Publication type:

Article

Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high‐dose statin.

Published in:

Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12308

By:

Fazio, Sergio;
Robertson, David G.;
Joh, Tenshang;
Wan, Hong;
Riel, Tom;
Forgues, Philippe;
Baum, Charles M.;
Garzone, Pamela D.;
Gumbiner, Barry

Publication type:

Article

The vasorelaxant effect of antidiabetic drug nateglinide via activation of voltage‐dependent K+ channels in aortic smooth muscle.

Published in:

Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12299

By:

Li, Hongliang;
Kim, Hye Won;
Shin, Sung Eun;
Seo, Mi Seon;
An, Jin Ryeol;
Jung, Won‐Kyo;
Ha, Kwon‐Soo;
Han, Eun‐Taek;
Hong, Seok‐Ho;
Bang, Hyoweon;
Choi, Il‐Whan;
Na, Sung Hun;
Park, Won Sun

Publication type:

Article

The effects of single‐ and multiple‐dose administration of bococizumab (RN316/PF‐04950615), a humanized IgG2Δa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastatin: Results from four phase I studies

Published in:

Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12309

By:

Gumbiner, Barry;
Joh, Tenshang;
Liang, Hong;
Wan, Hong;
Levisetti, Matteo;
Vana, Alicia M.;
Shelton, David L.;
Forgues, Philippe;
Billotte, Stephan;
Pons, Jaume;
Baum, Charles M.;
Garzone, Pamela D.

Publication type:

Article

Warfarin prescription in patients with nonvalvular atrial fibrillation and one non–gender‐related risk factor (CHA2DS2VASc 1 or 2): A treatment dilemma.

Published in:

Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12310

By:

Denas, Gentian;
Zoppellaro, Giacomo;
Padayattil Jose, Seena;
Antonucci, Emilia;
Marongiu, Francesco;
Poli, Daniela;
Testa, Sophie;
Tripodi, Armando;
Palareti, Gualtiero;
Pengo, Vittorio

Publication type:

Article

Works matching IS 17555914 AND DT 2018 AND VI 36 AND IP 1

Hemodynamic impact of pulmonary vasodilators on single ventricle physiology.

The effect of allogeneic cardiac stem cells in left ventricular geometry and function in a rat model of myocardial infarction.

Tetrahydrobiopterin (BH<sub>4</sub>): Targeting endothelial nitric oxide synthase as a potential therapy for pulmonary hypertension.

Issue Information.

The APEX trial: Effects of allopurinol on exercise capacity, coronary and peripheral endothelial function, and natriuretic peptides in patients with cardiac syndrome X.

Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high‐dose statin.

The vasorelaxant effect of antidiabetic drug nateglinide via activation of voltage‐dependent K<sup>+</sup> channels in aortic smooth muscle.

The effects of single‐ and multiple‐dose administration of bococizumab (RN316/PF‐04950615), a humanized IgG2Δa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastatin: Results from four phase I studies

Warfarin prescription in patients with nonvalvular atrial fibrillation and one non–gender‐related risk factor (CHA<sub>2</sub>DS<sub>2</sub>VASc 1 or 2): A treatment dilemma.